Update on eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
Hill
Anita
A
Department of Haematology, Bradford Teaching Hospitals, NHS Foundation Trust, Bradford, United Kingdom.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003167:Complement Activation / Q000187:drug effects; D003165:Complement System Proteins / Q000378:metabolism; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003165:Complement System Proteins; C481642:eculizumab